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Abstract 
This research include studying the oxidative stress state and measuring some biochemical parameters in the 
blood of β-thalassemia major which include: Acetylcholinesterase (AChE), Aspartate aminotransferase(AST), 
Alanine aminotransferase (ALT), Alkaline phosphatase (ALP),Catalase(CAT),Glutathione (GSH), 
Malonadialdehyde (MDA),Total bilirubin (Tb), Ceruloplasmin (Cp),Nitric oxid (NO) and  Peroxynitrite(ONOO-
). The study was done on (80) thalassemic patients (42) were male , (38)female and (40)  normal healthy 
subjects  as control group (21) were male and (19)female ,the age of  patients and control group ranged from 3-
30 years  for both sexes.The results showed that there was a significant increase in the activity of AChE,  AST, 
ALT, ALP, Cp,ONOO-and Tb in β-thalassemia major compared with healthy group for both sexes, these result 
were indicated that these parameters may be good biochemical markers for this disease .Beside of that, the 
results showed there was a highly oxidative stress in the patients for both sexes, so there was a significant 
increase in the activity of oxidant indicator of MDA, with a significant decrease in NO and GSH levels in 
thalassemic  patients compared with healthy group for both sexes. 
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1. Introduction  
Thalassemia Syndrome is among the most common genetic disorders of hemoglobin Synthesis worldwide [1]. 
the disorder was termed thalassemia, from the greek word , Thalassa which means (sea) and emia which means 
(blood) [2]. That refer to disorders associated with reduction synthesis of alpha (α) or beta globin (β) poly 
peptide chains caused to chronic hemolytic anemia since birth [3]. 
Thalassaemia causes varying degrees of anemia, which can range from mild anemia to significant life 
threatening anemia.These hematologic disorders range from asymptomatic to severe anemia that can caused 
significant morbidity and mortality[4]. β thalassemia are the most important types of thalassemia because they 
are so common and usually produce severe anemia in their homozygous and compound heterozygous states . 
Beta thalassemia major also called (Cooley anemia) characterized by severe illness with long-term, transfusion-
dependent anemia and entails a risk of iron overload and multiorgan involvement [5].  
  Oxidative stress is defined as the shift in the balance between the oxidants and antioxidants in favor of oxidants 
. The regulation of reducing and oxidizing, state is critical for cell activation, proliferation and organ function .It 
occurs when the generation of free radicals and active intermediates in a system override , the system ability to 
neutralize , and eliminate them [6]. In patients with beta thalassemia major where frequent blood transfusions 
are required due to severe anemia, oxidative stress occurs as a result of increased levels of lipid peroxides and 
free-radical intermediates, as well as the decrease in total antioxidant capacity. Use of iron chelatory agents in 
combination with antioxidants can be helpful in the regulation of the antioxidant status in patients with beta 
thalassemiamajor [7]. This oxidative stress and a possible consequential accelerated apoptosis may contribute to 
shortened life span of erythrocytes. Malondialdehyde (MDA), a product of lipid peroxidation is generated in 
excess amounts in supporting the fact that large amount of membrane bound iron is present in thalassemic 
erythrocytes [8]. 
Cholinesterase is a family of enzymes that catalyzes the hydrolysis of the neurotransmitter acetylcholine (ACh) 
into choline and acetic acid, a reaction necessary to allow a cholinergic neuron to return to its resting state after 
activation. It involves two types: 
(Acetylcholinesterase (AChE) and Pseudocholinesterase (PChE) the difference between the two types has to do 
with their respective preferences for substrates that AchE ehydrolyzes acetylcholin faster, while pchE 
hydrolyzes butyrylcholine faster [9]. Different aminotransferases show different tissue distribution: aspartate 
aminotransferaseactivity is high across most tissues, whereas alanine aminotransferase activity is highest in 
theliver. The alkaline phosphatase affects the inflammatory responses and may play a directrole in preventing 
organ damage [10].   Catalase, widely distributed in all cells, is present in high amounts in erythrocytes. It is 
responsible for detoxification of hydrogen peroxide in the cells [11].  Many foregoing studies have confirmed 
that most beta-thalassemia patients are under greater oxidative stress as evidenced by decreased plasma 
antioxidnt capacity, increased markers of oxidative damage. This status of oxidative stress is attributed to the 
toxicity of iron overload as a consequence of life-long blood transfusions, increased intestinal absorption of iron, 
and to the greater intravascular hemolysis, it is thus possible that the functional activity of Cp, which is a major 
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plasma antioxidant, is altered in a way to oppose and counteract the consequences of iron overload [12]. 
Pathological processes in thalassemia accelerate the destruction of (NO), and limit the compensatory increase 
in( NO) production[13]. ONOO- is a powerful oxidantcapable of oxidizing low density lipoproteins, of causing 
vascular dysfunction and is responsible for nitration of tyrosine residues in proteins. Therefore, the presence of 
nitrotyrosine in the plasma is considered to be an indirect measure of ONOO- [13]. 
The aim of the present investigation was to study the relationship between oxidative stress by measuring the 
MDA level, which is the marker of oxidative stress in thalassemia patients and study also measures some the 
enzymatic antioxidant and  biochemical parameters  level in thalassemic blood sample. 
2.  Materials and methods  
The study was done on (80) sample had β-thalassemia major (42) were male and(38) female and (40) were 
healthy subjects as control group(21) male and (19) female the age of thalassemic patients  ranged from 3- 30 
years for both sex.  Blood samples were collected from Azadi Teaching Hospital, Kirkuk, Iraq. All patients are 
diagnosed by specialist pediatrician. Different questions asked for patients and control groups that include 
medical history, Consanguinity of parents, Age at diagnosis of  thalassaemia, no, of blood transfusion/year, no, 
of DFO doses/week, Splenectomy, weight and  height. The biochemical test included each of  AChE, MDA 
,CAT ,Cp ,NO , ONOO- were manually measured while AST, ALT,ALP and Tb  were measured using the 
standard kits from Biolabo. 
Table 1: Methods used to estimate the biochemical parameters. 
Biochemical parameters The method 
AChE S-Acetylthiocholine Iodide method(14) 
AST and ALT Reitman and Frankel method(15) 
ALP Kind and King method(16) 
MDA Guidet,  B.; shah method(17) 
CAT  Abi,H. method(18) 
Cp Sunderman and Nomato method(19) 
NO Dervisevic and his colleagues method(20) 
ONOO- modified method.(21) 
3. Statistical analysis 
In this study the results include Mean ± SD and significant differences (p value) between groups that examined 
by a available statistical (SPSS 17.0), significant differences was estimated as the p value was equal or less than 
0.01 [22]. 
4. Results and Discussion   
4.1. Acetylcholinesterase (AChE) 
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AchE activity was found to be highly significant increase (P≤0.01) in patients with β-thalassemia major 
compared with control group as shown in tables (2) in both sexes. These results were agreed with previous 
results of the researchers [23]. May be attributed to lipid peroxidation, an index of oxidative stress.  
AChE has also been reported to be associated with stress responses and related to inflammation. In addition the 
results are consistent with previous studies which indicated that the level of enzyme increase, during apoptosis 
of the cells, as the oxidative stress stimulates the cortex of the thymus gland to secrete the enzyme, and induce 
AChE expression [24]. Several studies showing a high enzyme activity in patients with neurogical diseases for 
example, the high activity of enzyme in the saliva of Parkinson disease [25].and Al-zheimer patients was 
observed, this is due to the active role of enzyme in the formation and dissolution of the nerves or may result in 
damage to brain and nerve tissue, or to the immune role played by molecular neurotransmitter Ach ,and 
therefore has a role in many neurogical disease [26]. The increase in enzyme activity can be attributed to the 
conditions of depression, anxiety, boredom and sadness, this confirms the relationship between this disorder and 
psychiatric health and psychiatric disorder [27]. The effect of estrogen on the brain and its stimulation to pull of 
choline and further build the acetylcholine, may be the reason for the higher activity of enzyme in male than 
female [23] . 
Table 2: The activity of AChE in the Blood of Patients and  Control for both sexes. 
P≤ Patients Control Gender Parameters 
0.01 6.21±1.18 4.39± 1.03 General 
Mean± S.D. AchE 
 (µmol/ml/min) 
0.01 6.200± 1.384 4.598±1.176      Male 
0.01 5.414±0.921 4.154±0.807 Female 
4.2. Levels of  0xidative Stress Marker(MDA) With Antioxidant parameters ( GSH ,CAT,  Cp)  
MDA is good indicator of oxidative damage .In addition, MDA represents the end product of polyunsaturated 
fatty acid oxygenation is commonly used as the lipid peroxidation level marker and the level of the presence of 
oxidative stress [28]. 
The results in tables (3) showed that there was a significant increase (p<0.01)  in the levels of MDA in patients 
with β-thalassemia major. Our study confirm that, in thalassemia there is excess  production of reactive oxygen 
intermediates, such as superoxide anion (O2 –), hydroxyl radical (OH·), singlet oxygen andhydrogen peroxide 
(H2O2) within the erythrocytes, all these events leads to oxidative stress. This oxidative stress and a possible 
consequential accelerated apoptosis may contribute to shortened life span of erythrocytes. MDA, a product of 
lipid peroxidation is generated in excess amounts in supporting the fact that large amount of membrane bound 
iron is present in thalassemic erythrocytes [29]. Iron are also implicated as causative agents in excessive 
generation of free radical which are capable of causing oxidative damage to erythrocytes. Our results agree with 
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those of  ElalfyMS and his colleagues (2013)[30],  and Hasan F  AL –Azzawie and his colleagues (2017)[31] 
,This oxidative stress will cause growth failure as well as liver, cardiovascular, endocrine and neurological 
complications in  thalassemia major. Peroxidative damage of lipids is indicated by the increase in serum MDA 
and decreased antioxidant defence mechanism play an important role in the pathogenesis of _ thalassemia 
major[32]. It requires adequate treatment in thalassaemic so that the early deaths especially from iron induced 
cardiomyopathies 
As a result of continuous blood transfusions, the patients might be subjected to peroxidative tissue injury by the 
secondary iron overload. These findings might support the idea that iron overload in thalassemia leads to an 
enhanced generation of reactive oxygen species and oxidative stress. It also correlate with the study of Elham 
Abed Mahdi in 2014 [33],GSH is a major intracellular reducing agent which is very sensitive to oxidative 
pressures and it  has a substantial factor in protecting body tissue and cells against the ROS damage. GSH 
protects plasma membrane from lipid peroxidation, regulation of gene expression, neutralizes the oxidative 
factors and prevents its formation [34].  
The results of the current study indicate a significant decrease (P≤0.01)  in the level of GSH as compared with 
control as shown in tables (3)  .Our results are  in good agreement with the result of study done by Muaid  SAS 
and his colleagues (2015) [35] ,and Muanprasat C and his colleagues (2013) [36]. Where they confirmed that 
GSH  level will be low in β –thalassemia major . 
Catalase, widely distributed in all cells, is present in high amounts in erythrocytes. It is responsible for 
detoxification of hydrogen peroxide in the cells. In present study, catalase was significantly decrease (P≤0.05) in 
the levels of CAT in thalassemia patients as compared with healthy controls as shown in tables (3) .This  could 
be due to increase in the lipid per oxidation product malondialdyhyde, which can form cross links, therapy 
inactivating several membrane bound enzymes[11]. Our results are in good agreement with the study done by  
Elham Abed Mahdi in 2014 [33], Choudhary ,M,(2017) [37]and Hasan F  AL –Azzawie and his colleagues 
(2017)[31 ] , in which  they found that, a greater amount of hydrogen peroxide might produce directtoxic 
damage to catalase, the concentration of this is considerably reduced in conditions of high oxidative stress. On 
the other hand,the decrease in CAT activity in patients may be due to the decrease in nicotinamide adenine 
dinucleotide phosphatase (NADPH) that is crucial for the maintenance of CAT activity because CAT monomer 
contains a high affinity binding site for NADPH. A second contributing cause may be at play. It is possible that 
iron may deplete H2O2 through Fenton chemistry, which would result in loss of induction of CAT expression 
by H2O2. Iron converts hydrogen peroxide to hydroxyl radical, peroxyl radical, and hydroxyl anion. It is 
notable that production of hydroxyl and peroxyl radicals may accentuate lipid peroxidation chain reactions, this 
would explain the association of this disorder with lipid peroxidation [38]. 
 While its not agreed with the research of Qaiser, S and his colleagues (2015) [39] ,  Boudrahem. Addour and 
his colleagues (2014) [40], andSandra,S and his colleagues (2015) [41] ,in which they  suggested that, the 
peroxidative status generated by (ROS) in beta thalassemia major patients may lead to significantly increased  in 
catalase  activity. 
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The results in tables (3) showed that there was a significant increase (p<0.01)  in the levels of Cp in thalassemic 
patients as compared to control .The high serum levels of Cp  observed in our patients might be attributed to 
several iron overload related mechanism: 
 1- It is possible that the levels were increased to prevent the formation of (ROS) through the Fenton 
reaction. This is achieved by the antioxidative capacity of Cp through the oxidation of Fe2+to Fe3+, 
thus preventing oxidative damage of lipids, proteins and DNA [42]. 
2- Oxidation of the ferrous form of iron to the ferric form enhancesits binding with transferrin and thus its 
transport to storage and/or utilization sites. 
3- It is possible that Cp levels were increased in response to hypoxia and ineffective erythropoiesis. 
 4-  It is possible that Cp is increased in response to accumulated iron in tissues, thus enhancing efﬂux of 
iron into transferrin in plasma. Several studies    have provided evidence supporting the function of Cp 
in mobilization of iron between tissues and plasma [43]. 
Table 3: The level of (GSH, MDA,CATandCp)in  the Blood of Patients and Control for both sexes . 
P≤ Patients Control Gender Parameters 
0.01 5.39±1.39 3.415±0.750 General 
Mean± S.D MDA 
µmol/L 0.01 5.125±1.100  0.787  ± 3.504 Male 
0.01 5.687±1.610 3.318±0.715 Female 
0.01 4.65±1.17 8.67±1.08 General Mean± S.D  
GSH 
µmol/L 
0.01 4.646±1.234 0.934±8.623 Male 
0.01 4.657±1.104 8.723±1.245 Female 
0.01 0.157±0.038 0.198±0.029 General 
Mean± S.D  
CAT 
K/ml 
0.01 0.152±0.087 0.123±0.173 Male 
0.01 0.148±0.133 0.194±0.130 Female 
0.01 0.308±0.123 0.1503±0.0462 General 
Mean± S.D 
Cp 
g/L 
0.01 0.3002±0.105 0.1439±0.0442 Male 
0.01 0.317±0.140 0.157±0.0462 Female 
 
 4.3. liverFunctionTest (ALT,AST,ALPandTotal Bilirubin ) Concentration 
From the data presented in table(4),it appear that there is a highly significant increase (p≤0.01) in the activity of  
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liver function enzymes (ALT, AST, ALP) in patients with β-thalassemia major Moreover, there is a high 
significant increase (p≤ 0.01) in the concentration of total bilirubin, as compared with the control group for both 
sexes . 
Table 4: The level of (ALT,AST,ALPand TB)in  the Blood of Patients and Control for both sexes . 
P≤ Patients Control Gender Parameters 
0.01 55.5±19.07 21.98± 6.99 General 
Mean± S.D ALT 
IU/L 
0.01 57.38±50.35  6.42  ± 21.24 Male 
0.01 53.53±50.36 22.79±7.67 Female 
0.01 52.6±17.08 23.00±5.72 General Mean± S.D  
AST 
IU/L 
0.01 56.57± 17.32 5.52±22.48 Male 
0.01 48.13± 20.54 23.58±6.04 Female 
0.01 173.4±32.1 113.3±21.8 General Mean± S.D  
ALP 
IU/L 
0.01 169.62±33.27 20.04±107.95 Male 
0.01 177.58±30.27  119.16±22.76 Female 
0.01 3.226±0.978 0.868±0.154 General Mean± S.D 
TB 
mg/dl 
0.01 3.317±0.895 0.881±0.928 Male 
0.01 3.126±1.065 0.852±0.203 Female 
When certain types of cells are damaged they may leak enzymes into the blood stream, where they can be 
measured as indicators of cell damage. ALT , AST and ALP are such enzymes. 
ALT is highly specific for hepatocellular damage, and could be due to liver damage secondary to iron overload, 
the level of it is increased in any hepatic injury or it may be high before the appearance of hepatic diseases like 
jaundice. AST displays its powerful activity in an alkaline environment and is particularly concentrated in liver, 
bones, and muscles. Thus, high levels of (AST) in the blood suggest medical conditions that affect the heart, 
liver, or muscles. Higher levels are seen in extrahepatic bile obstruction, intrahepatic cholestasis, infiltrative 
liver disease and hepatitis [44]. 
Alp is mainly expressed in variety of tissues, in bones , Liver. The elevations  of serum Alp activity ( hyper 
alkaline phosphatasemia) , is seen with more specivie disorders such as , malignant biliary obstruction , biliary 
cirrhosis , hepatic lymphoma , liver disease , hepatitis , paget disease , bone cancers and cholangitis [45].  
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In the current study, we have found the elevated levels of ALP as well. This is mainly caused by leakage of the 
enzymes from cytoplasmic and mitochondrial compartments of injured hepatocytes to the plasma. It can be 
concluded that the high levels of hepatic enzymes are possibly due to the hepatic injury, caused by iron overload 
in thalassemic patients receiving multiple blood transfusion. The results of the present study are thus concurrent 
with the results of other studies [46,47]. Moreover, there is a high significant increase (p≤ 0.01) in the 
concentration of total bilirubin in thalassaemic patients as compare with control subjects .This could be due to 
destruction of RBCs and hemolysis of immature RBCs in spleen that occurred in thalassaemic patients and the 
liver's decreased ability to conjugate the bilirubin. Iron overload could potentially induce hepatic toxicity, and 
consequently increased bilirubin concentrations . This result was in agreement with other studies [48,49] . 
4.4. Nitric Oxide and Peroxynitrite  Concentration 
Results in table (5) have shown highly significant increase (p≤0.01) in the concentration of  peroxynitrite, and 
highly significant decrease (p≤0.01) in the concentration of nitric oxide in the blood of  β-thalassemia major 
patients  ,compared with control group . 
Table 5: The level of (NO and ONOO-) in  the Blood of Patients and Control for both sexes . 
P≤ Patients Control Gender 
Group 
Parameter 
0.01 5.15±1.45 11.60± 3.32 General 
 Mean ± S.D. NO nmol/ml 
0.01 4.896± 1.029 11.548±2.991 Male 
0.01 5.966±0.884 11.647±3.732 Female 
0.01 68.8±15.9 57.8±13.5 General 
 Mean ± S.D. ONOO- µmol/L   0.01 70.82±17.90 58.95±13.81 Male 
0.01 66.59±13.27 56.51±13.32 Female 
 Hemoglobinopathies characterized by chronic hemolysis are currently considered sources of strong oxidative 
stress. Free heme and the red cell membrane elements that are produced during hemolysis have a negative effect 
on( NO) and arginine availability, which in turn promotes vasoconstriction. They also lead to further endothelial 
dysfunction, resulting in a more pronounced ( NO) reduction [50].  Hemolysis and repeated blood transfusions 
cause decreases in nitric oxide levels and iron overload in various organs, including the brain. Increased iron in 
the brain leads to oxidative stress and possible irreparable brain tissue damage, causing cognitive impairment. In 
hemoglobinopathies, NO binds very rapidly to deoxyhemoglobin, forming a stable Hb (Fe+2)-NO complex. NO 
also reacts with and converts oxygenated hemoglobin to methemoglobin and nitrate (NO3 -).  Pathological 
processes in thalassemia accelerate the destruction of ( NO), and limit the compensatory increase in( NO) 
production [51]. We found that serum NO levels in beta-thalassemia major patients were significantly lower 
than those in control, that is significantly correlated with oxidative stress .   Our results are in good agreement 
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with the study done by Nihayat Bayraktar and his colleagues (2008) [52], in which they found that, Lowered 
level of NO might be explained by hemolysis-associated endothelial dysfunction, thalassemia major are 
probably associated with more severe degrees of hemolysis. The body’s immunosurveillance may prove 
ineffective if the generation of peroxynitrite is enhanced tremendously, as seen in chronic inflammation and in 
injured tissues. Once peroxynitrite level increases, the damage and nitration would be inevitable and the 
immunoregulatory network would be activated resulting in the production of autoantibodies. Cellular 
metabolism and ionization radiation produces both reactive nitrogen and oxygen species. These radicals and 
their subsequent intermediates may react with cellular macromolecules and induce a variety of chemical 
alterations leading to autoantibodies [53]. 
 5. Conclusion 
1-  Thalassaemic patients were have a higher AchE activity compared to the control group . 
2- Iron overload gives rise to oxidative stress through free radical formation. 
3- Oxidative stress and reduced antioxidant defense mechanism play an important role in complications of 
β-thalassaemia major patients.  
4-There is a direct effect of iron overload on liver injury. 
5-There was significant increase in concentration of Serum ONOO- ,and reduction in serum of NO for 
thalassemic patients . 
6.  Recommendations 
1-The possibility of using the enzymes AChE, AST and APT, as biochemical parameters to follow the 
severity of the disease. 
2-Conducting studies in the β-thalassaemia major to estimate more biochemical parameters and study its 
relation with the disease.  
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